- Awards
- 17
- Value outside frameworks
- £3.1m
- Framework places
- 2
- Shared awards
- 11
Values exclude VAT where the notices give it, and only values in pounds are added up. A framework place carries the framework's whole ceiling, shared with the other suppliers on it, so framework places are counted rather than added up; so are awards made to several suppliers together.
Awards
| Procurement | Buyer | Value | Date |
| CAR-T Therapy - Yescarta & Tecartus (axicabtagene ciloleucel & brexucabtagene autoleucel) |
The Clatterbridge Cancer Centre NHS Foundation Trust |
£893,953 |
19 Oct 2026 |
| NHS National Generic Pharmaceuticals - Wave 16a framework |
NHS England |
£393,331,872 |
27 Aug 2026 |
| Remdesivir Infusion |
Southern Health and Social Care Trust |
£300,000 |
29 Apr 2026 |
| Biktarvy |
Southern Health and Social Care Trust |
£1,200,000 |
28 Apr 2026 |
| Provision of CAR-T Cells |
The Clatterbridge Cancer Centre NHS Foundation Trust |
£727,348 |
6 Mar 2026 |
| NHS England procurement for the supply of Pan-genotypic Direct Acting Antiviral (DAA) Hepatitis C treatments and the provision of Hepatitis C elimination initiatives framework |
NHS England |
£160,000,000 |
25 Feb 2026 |
| NHS Framework for the Midlands and East, Branded Medicines - Tranche B shared |
NHS England |
£228,156,862 |
25 Jan 2021 |
| NHS Framework for the NHS London Region, Branded Medicines - Tranche A shared |
NHS England |
£191,062,951 |
17 Jun 2020 |
| NHS Framework Agreement - North of England - Tranche B shared |
NHS England |
£205,535,556 |
13 Feb 2020 |
| NHS South of England Branded Medicines - Tranche A - Contracts Finder Award Notice shared |
NHS England |
£188,004,961 |
1 Aug 2019 |
| NHS Framework Agreement for Branded medicines - London - Tranche B - Contracts Finder Opportunity shared |
NHS England |
£251,930,337 |
5 Jul 2019 |
| NHS Framework Agreement for Branded Medicines - National shared |
NHS England |
£1,351,341,890 |
1 May 2019 |
| NHS England - Midlands and East Branded Medicines - Tranche B shared |
NHS England |
£295,035,882 |
17 Jan 2019 |
| NHS England - Midlands and East Branded Medicines - Tranche B shared |
NHS England |
£295,035,882 |
17 Jan 2019 |
| NHS England - Midlands and East Branded Medicines - Tranche B shared |
NHS England |
£295,035,882 |
17 Jan 2019 |
| NHS England - Midlands and East Branded Medicines - Tranche B shared |
NHS England |
£295,035,882 |
17 Jan 2019 |
| NHS England Framework Agreement: South of England (Tranche B) shared |
NHS England |
£501,400,000 |
14 Sep 2018 |
Top buyers
By number of awards. Value is the total of awards made to this supplier alone outside frameworks, excluding VAT where the notices give it.